Poster: AML-295 AGILE: A Global, Randomized, Double-Blind, Phase 3 Study of Ivosidenib + Azacitidine Versus Placebo + Azacitidine in Patients With Newly Diagnosed Acute Myeloid Leukemia With an IDH1 Mutation

Authors :: Hartmut Dohner
Pau Montesinos
Susana Vives Polo
Ewa Zarzycka
Jianxiang Wang
Giambattista Bertani
Michael Heuser
Rodrigo T. Calado
Andre C. Schuh
Su-Peng Yeh
Adolfo de la Fuente
Claudio Cerchione
Scott R. Daigle
Jianan Hui
Shuchi S. Pandya
Diego A. Gianolio
Christian Recher
Stephane de Botton
Source :: Clinical Lymphoma Myeloma and Leukemia. 22:S124
Publication Year :: 2022
Publisher :: Elsevier BV, 2022.

Full Text Access

Tools